Skip to content

Aquestive Therapeutics

US · AQST #3650 by market cap Listed 2018
3.46 -0.25 -6.61%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Aquestive Therapeutics

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Founded
2004
CEO
Mr. Daniel Barber
Employees
147
Headquarters
Warren, New Jersey, United States of America
Fiscal year end
12-31
Website
aquestive.com

Company profile

Exchange
US
Symbol
AQST
Market-cap rank
#3650
Listing date
2018-07-25
Market cap
434.88M
Float cap
391.62M
Shares out
125.69M
Float shares
113.19M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.

Aquestive Therapeutics discussion 0 comments

Add a comment